Gibbs offers trial for lung cancer patients
Wed, 07/09/2014 - 14:26
Amanda Irwin
As part of a public and private collaboration, the Gibbs Cancer Center & Research Institute has been selected as one of the first 10 test sites in the world for a clinical cancer drug trail for patients with squamous cell lung cancer.
Full text available to premium subscribers only. If you are a current subscriber, please login for full access. If you would like to subscribe, please click here for our subscription options. Thank you.
